COMMUNIQUÉS West-GlobeNewswire

Conatus Pharmaceuticals Announces Publication Demonstrating that Emricasan Ameliorates Portal Hypertension, Improves Liver Structure and Function in a Preclinical Model of Advanced Cirrhosis

30/04/2019 - 13:30

SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced a new publication 1 in Hepatology Communications detailing results following seven-day treatment with emricasan, [...]

Kura Oncology to Report First Quarter 2019 Financial Results

30/04/2019 - 13:30

SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will [...]

Avenue Therapeutics Announces Appointment of Dr. Thomas G. Moore to Board of Directors

30/04/2019 - 13:30

NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol, today [...]

BeyondSpring Provides Business Update and Fourth Quarter and Full-Year 2018 Financial Results

30/04/2019 - 13:30

- Significant Clinical Data Generated for Plinabulin - - On Track to Submit New Drug Applications (NDAs) for Plinabulin to China’s National Medical Products Administration (NMPA) for Both Non-Small Cell Lung Cancer ( [...]

Aptinyx Reports Positive Data from Phase 1 Study of Novel NMDA Receptor Modulator, NYX-458, in Healthy Volunteers

30/04/2019 - 13:27

Favorable overall safety, tolerability, and pharmacokinetic profile — no serious adverse events reported across wide dose range Achieved ample CNS exposure consistent with exposure observed at preclinically efficacious [...]

Cure Pharmaceutical [OTCQB:CURR] to Present at the “Planet MicroCap Showcase 2019”

30/04/2019 - 13:25

CURE CEO to discuss expanded product pipeline and company’s continued execution into cannabinoid market. LAS VEGAS, April 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and [...]

AGTC to Host Third Quarter Financial Results Conference Call and Webcast on May 7, 2019

30/04/2019 - 13:00

GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]

ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual Meeting

30/04/2019 - 13:00

Eleven relevant presentations are scheduled, covering all five ImprimisRx portfolios SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the ophthalmology-focused pharmaceutical compounding subsidiary of Harrow [...]

Trillium Announces Management and Board Changes and Provides Corporate Update

30/04/2019 - 13:00

TORONTO, April 30, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of [...]

Codexis Signs Multi-Year Enzyme Supply and Licensing Agreement with Tate & Lyle for the Manufacture of TASTEVA® M Stevia Sweetener

30/04/2019 - 13:00

Codexis’ breakthrough enzyme cascade system enables better-tasting stevia product launch REDWOOD CITY, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, [...]

IRADIMED CORPORATION Announces First Quarter 2019 Financial Results

30/04/2019 - 13:00

Reports first quarter 2019 revenue of $8.4 million Reports first quarter 2019 GAAP diluted EPS of $0.15 and non-GAAP diluted EPS of $0.13 WINTER SPRINGS, Fla., April 30, 2019 (GLOBE NEWSWIRE) -- iRadimed Corporation ( [...]

Axovant Announces Dosing of First Patient in Second Cohort of SUNRISE-PD Phase 2 Trial of AXO-Lenti-PD

30/04/2019 - 13:00

-Up to 6 patients to be enrolled in the second cohort, initial data expected in fourth quarter 2019- -Oral presentation at the Annual Meeting of the American Society of Gene and Cell Therapy- BASEL, Switzerland, April [...]

RedHill Biopharma to Host First Quarter 2019 Financial Results Conference Call on May 7, 2019

30/04/2019 - 13:00

TEL-AVIV, Israel and RALEIGH, N.C., April 30, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ( Nasdaq : RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company [...]

Kane Biotech Provides Update on Exclusive License and Distribution Agreement with Dechra Veterinary Products

30/04/2019 - 12:55

Agreement with Dechra leads to Growing Royalty Revenues Following Product Expansion, Growing Sales Demand and Broader Veterinary Approval WINNIPEG, Manitoba, April 30, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: [...]

Teleflex to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

30/04/2019 - 12:45

WAYNE, Pa., April 30, 2019 (GLOBE NEWSWIRE) -- Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Merrill Lynch 2019 Health Care Conference at the Encore Hotel [...]

The Ensign Group Schedules First Quarter 2019 Earnings Call for Tuesday, May 7, 2019

30/04/2019 - 12:00

MISSION VIEJO, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign (TM) group of skilled nursing, rehabilitative care services, assisted living, home health [...]

Amicus Therapeutics Presents Positive Preclinical Pompe Disease Gene Therapy Data at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting

30/04/2019 - 12:00

Preclinical Studies Show Robust Uptake and Glycogen Reduction in Multiple Tissues, Including Brain and Spinal Cord Initial Validation for Collaboration Combining Amicus-Engineered Transgenes with Penn’s AAV Gene Therapy [...]

PCI Biotech: Invitation to first quarter 2019 result presentation

30/04/2019 - 11:13

Oslo, Norway, 30 April 2019 - PCI Biotech invites to a presentation of the company's first quarter 2019 result on Wednesday 8 May 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday 8 May, 08:30am – 09:30am [...]

Capital Senior Living Corporation Announces Release Date for First Quarter 2019 Financial Results

30/04/2019 - 11:00

DALLAS, April 30, 2019 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (NYSE:CSU) will host a conference call with senior management to discuss the Company’s first quarter 2019 financial results. The call will be [...]